Inmune Bio (INMB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.57, -4.85% vs the prior close of $1.65.
- Volume 196.17K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
INMB slides 4.8% to $1.57, a 3-month low. Closed at $1.57, -4.85% vs the prior close of $1.65. Day range $1.56–$1.68, opened at $1.68.
INMB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — INMB slides 4.8% to $1.57, a 3-month low
- Closed at $1.57, -4.85% vs the prior close of $1.65. Day range $1.56–$1.68, opened at $1.68.
- Volume was 196.17K shares, 0.5x its 50-day average of 359.56K — lighter than usual.
- Price is -25.7% vs its 50-day average ($2.11) and -4.1% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 32% of that range, 39.6% below the 52-week high.
Oct 15, 2026 — INMB jumps 3.1% to $1.65
- Closed at $1.65, +3.12% vs the prior close of $1.60. Day range $1.53–$1.68, opened at $1.60.
- Volume was 625.50K shares, 1.8x its 50-day average of 356.87K.
- Price is -22.2% vs its 50-day average ($2.12) and +0.8% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 37% of that range, 36.5% below the 52-week high.
Oct 14, 2026 — INMB slides 4.8% to $1.60, a 3-month low on 3.3x normal volume
- Closed at $1.60, -4.76% vs the prior close of $1.68. Day range $1.59–$1.91, opened at $1.70.
- Volume was 1.14M shares, 3.3x its 50-day average of 342.43K — unusually heavy trading.
- Price is -24.7% vs its 50-day average ($2.12) and -2.3% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 34% of that range, 38.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — INMB slides 5.6% to $1.68, a 1-month low
- Closed at $1.68, -5.62% vs the prior close of $1.78. Day range $1.64–$1.79, opened at $1.77.
- Volume was 247.30K shares, 0.7x its 50-day average of 341.94K.
- Price is -21.2% vs its 50-day average ($2.13) and +2.6% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 39% of that range, 35.4% below the 52-week high.
Oct 12, 2026 — INMB slides 5.8% to $1.78, a 1-month low
- Closed at $1.78, -5.82% vs the prior close of $1.89. Day range $1.78–$1.89, opened at $1.89.
- Volume was 72.70K shares, 0.2x its 50-day average of 345.00K — lighter than usual.
- Price is -16.6% vs its 50-day average ($2.13) and +8.6% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 46% of that range, 31.5% below the 52-week high.
Oct 9, 2026 — INMB jumps 3.3% to $1.89
- Closed at $1.89, +3.28% vs the prior close of $1.83. Day range $1.84–$1.91, opened at $1.84.
- Volume was 91.60K shares, 0.3x its 50-day average of 345.85K — lighter than usual.
- Price is -11.4% vs its 50-day average ($2.13) and +15.4% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 53% of that range, 27.3% below the 52-week high.
Oct 8, 2026 — INMB dips 1.6% to $1.83, a 1-month low, 3 down days in a row
- Closed at $1.83, -1.61% vs the prior close of $1.86. Day range $1.79–$1.87, opened at $1.85.
- Volume was 379.10K shares, 1.1x its 50-day average of 342.52K.
- Price is -14.1% vs its 50-day average ($2.13) and +11.7% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 49% of that range, 29.6% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — INMB dips 0.5% to $1.86, a 1-month low
- Closed at $1.86, -0.53% vs the prior close of $1.87. Day range $1.82–$1.88, opened at $1.82.
- Volume was 104.40K shares, 0.3x its 50-day average of 343.04K — lighter than usual.
- Price is -12.6% vs its 50-day average ($2.13) and +13.6% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 51% of that range, 28.5% below the 52-week high.
Oct 6, 2026 — INMB slides 3.6% to $1.87, a 1-month low
- Closed at $1.87, -3.61% vs the prior close of $1.94. Day range $1.82–$1.98, opened at $1.95.
- Volume was 310.00K shares, 0.9x its 50-day average of 340.43K.
- Price is -12.0% vs its 50-day average ($2.13) and +14.2% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 52% of that range, 28.1% below the 52-week high.
Oct 5, 2026 — INMB rises 0.5% to $1.94
- Closed at $1.94, +0.52% vs the prior close of $1.93. Day range $1.88–$1.97, opened at $1.90.
- Volume was 267.00K shares, 0.8x its 50-day average of 338.81K.
- Price is -8.6% vs its 50-day average ($2.12) and +18.5% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 56% of that range, 25.4% below the 52-week high.
Oct 2, 2026 — INMB ends flat (+0.0%) to $1.93, 5 down days in a row
- Closed at $1.93, +0.00% vs the prior close of $1.93. Day range $1.93–$2.00, opened at $1.97.
- Volume was 290.20K shares, 0.9x its 50-day average of 339.28K.
- Price is -8.8% vs its 50-day average ($2.12) and +17.9% vs its 200-day average ($1.64).
- 52-week range $1.09–$2.60; today's close sits at 56% of that range, 25.8% below the 52-week high.
- That makes 5 straight losses.
INMB latest news & SEC filings
Every SEC filing by or about INMB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 23, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.27M (prior year -$24.46M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$1.05) (loss narrowed vs Jun 30, 2025)
Jul 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade INMB
- Last results release: Oct 30, 2025 (8-K Item 2.02). Previous ones: Aug 7, 2025, May 8, 2025, Mar 27, 2025. Based on that rhythm, the next report is likely around Jan 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.75% (largest 7.4%).
- Liquidity: about 313.60K shares (≈$492.35K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.57 vs a range of $1.09–$2.60 (32% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 14, 2026; 10-Q Aug 6, 2026; 8-K Jul 31, 2026.
- Share count: 27.75M shares outstanding (Aug 6, 2026), +4.4% vs a year earlier.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
INMB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.68 | 1.68 | 1.56 | 1.57 | 196.17K |
| Oct 15, 2026 | 1.60 | 1.68 | 1.53 | 1.65 | 625.50K |
| Oct 14, 2026 | 1.70 | 1.91 | 1.59 | 1.60 | 1.14M |
| Oct 13, 2026 | 1.77 | 1.79 | 1.64 | 1.68 | 247.30K |
| Oct 12, 2026 | 1.89 | 1.89 | 1.78 | 1.78 | 72.70K |
| Oct 9, 2026 | 1.84 | 1.91 | 1.84 | 1.89 | 91.60K |
| Oct 8, 2026 | 1.85 | 1.87 | 1.79 | 1.83 | 379.10K |
| Oct 7, 2026 | 1.82 | 1.88 | 1.82 | 1.86 | 104.40K |
| Oct 6, 2026 | 1.95 | 1.98 | 1.82 | 1.87 | 310.00K |
| Oct 5, 2026 | 1.90 | 1.97 | 1.88 | 1.94 | 267.00K |
| Oct 2, 2026 | 1.97 | 2.00 | 1.93 | 1.93 | 290.20K |
| Oct 1, 2026 | 1.96 | 1.97 | 1.88 | 1.93 | 340.80K |
| Sep 30, 2026 | 1.98 | 2.02 | 1.94 | 1.95 | 201.30K |
| Sep 29, 2026 | 2.01 | 2.02 | 1.94 | 1.96 | 286.50K |
| Sep 28, 2026 | 2.02 | 2.05 | 1.94 | 2.00 | 191.60K |
| Sep 25, 2026 | 2.01 | 2.04 | 1.96 | 2.03 | 193.60K |
| Sep 24, 2026 | 2.00 | 2.01 | 1.94 | 2.00 | 167.90K |
| Sep 23, 2026 | 2.15 | 2.17 | 1.99 | 2.00 | 487.60K |
| Sep 22, 2026 | 2.31 | 2.36 | 2.16 | 2.16 | 375.50K |
| Sep 21, 2026 | 2.35 | 2.42 | 2.29 | 2.29 | 306.70K |
About Inmune Bio
Inmune Bio (INMB) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in BOCA RATON, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1711754.
INMB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Marcia Allen | Director | Dec 2, 2025 |
| Ronnie Duane Clark | Director | Sep 23, 2026 |
| James Kelly Ganjei | Director | Dec 2, 2025 |
| Scott Juda | Director | Jul 7, 2026 |
| David J Moss | Chief Executive Officer | Jul 7, 2026 |
| James Sapirstein | Director | Sep 17, 2026 |
| Timothy J Schroeder | Director | Dec 2, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Cory Randall Ellspermann | CFO | Dec 2, 2025 |
| Mark William Lowdell | Chief Scientific Officer | Jul 7, 2026 |
| David J Moss | Chief Executive Officer | Jul 7, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
INMB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $50.00K | $-45.93M | -1.86 | $-22.58M |
| Dec 31, 2024 | $14.00K | $-42.08M | -2.11 | $-33.36M |
| Dec 31, 2023 | $155.00K | $-30.01M | -1.67 | $-11.98M |
| Dec 31, 2022 | $374.00K | $-27.30M | -1.52 | $-22.69M |
| Dec 31, 2021 | $181.00K | $-30.34M | -1.88 | $-28.50M |
Latest balance sheet: total assets $26.84M, total liabilities $6.48M, cash $24.75M (as of Jun 30, 2026).
INMB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 30, 2025 | 8-K Item 2.02 (results) | $1.73 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $2.79 |
| May 8, 2025 | 8-K Item 2.02 (results) | $7.09 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $7.41 |
| Nov 1, 2024 | 8-K Item 2.02 (results) | $6.04 |
| Aug 2, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
| Aug 8, 2023 | 8-K Item 2.02 (results) | — |
| May 4, 2023 | 8-K Item 2.02 (results) | — |
| Mar 3, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on INMB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.